Results 171 to 180 of about 28,675 (247)

Is MR Imaging of the Cervical Spinal Cord Sufficient for Patients with Suspected Multiple Sclerosis? [PDF]

Clin Neuroradiol
Riederer I, Bussas M, Lauerer M, Harabacz L, Pineker V, El Husseini M, Sollmann N, Zimmer C, Kirschke JS, Mühlau M.   +9 more
europepmc   +1 more source

Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis. [PDF]

J Neurol
Muñoz-Vendrell A, Arroyo-Pereiro P, León I, Bau L, Matas E, Romero-Pinel L, Roca-Pereira S, Martínez-Yélamos A, Martínez-Yélamos S.   +8 more
europepmc   +1 more source

A potential of serum anti-C1P IgG antibodies as biomarkers in differential diagnosis of relapsing-remitting multiple sclerosis. [PDF]

Sci Rep
Chojdak-Lukasiewicz J, Jakubiak-Augustyn A, Szulc ZM, Gubernator J, Blazej P, Pokryszko-Dragan A, Budrewicz S, Podbielska M.   +7 more
europepmc   +1 more source

Sex-Related Differences in Circular RNA Expression in Multiple Sclerosis: A Pilot Study. [PDF]

J Mol Neurosci
Lodde V, Zarbo IR, Farina G, Zoroddu E, Solla P, Delogu G, Gorospe M, Floris M, Campesi I, Idda ML.   +9 more
europepmc   +1 more source

Can Multiple Sclerosis be Managed Over a Lifetime? A Rare 72-Year Journey of Pediatric-Onset to Secondary Progressive Multiple Sclerosis. [PDF]

Clin Case Rep
Etemadifar M, Dehghani A, Rahimi M, Ghandehari A, Salari M.   +4 more
europepmc   +1 more source

Ocrelizumab-Induced Brain Volume Dynamics in Relapsing-Remitting Multiple Sclerosis. [PDF]

Pharmaceuticals (Basel)
De Masi R, Orlando S.
europepmc   +1 more source

The predictive value of serum neurofilament light chain in achieving no evidence of disease activity-3 (NEDA-3) status in treatment-naïve patients with multiple sclerosis. [PDF]

J Neurol
Dimitriadou EM, Tzanetakos D, Theodorou A, Akrivaki A, Papadopoulos D, Mastorodemos V, Maleska A, Sotirli SA, Fakas N, Stergiou C, Kitsos D, Giannopapas V, Moschovos C, Giannopoulos S, Kuhle J, Tsivgoulis G, Tzartos JS.   +16 more
europepmc   +1 more source

Testosterone in Relapsing-Remitting Multiple Sclerosis: A Case-Control Study. [PDF]

J Clin Med
Rościszewska-Żukowska I, Popiel M, Perenc A, Rudnicka-Czerwiec J, Malska I, Bartosik-Psujek H.   +5 more
europepmc   +1 more source

Patient‑Reported Satisfaction in Relapsing-Remitting Multiple Sclerosis: Advantages of At‑Home Self‑Administered Subcutaneous Ofatumumab Versus Other High‑Efficacy Therapies. [PDF]

Drugs Real World Outcomes
Pastore F, Domenicone E, DellOro P, Lefort C.   +3 more
europepmc   +1 more source